Altogether, our study indicates that supplementation of cyclocreatine targeting microglial metabolism may be promising for therapeutic intervention in ischemic stroke, even in the absence of Trem2, the mechanisms of which is closely associated with regulation of Igf1 expression. The gene discussed is IGF1; the disease is ischemic stroke.